|
1
|
Law SK, Shih K, Tran DH, Coleman AL and
Caprioli J: Long-term outcomes of repeat vs initial trabeculectomy
in open-angle glaucoma. Am J Ophthalmol. 148:685–695.e1. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Steplewski A and Fertala A: Inhibition of
collagen fibril formation. Fibrogenesis Tissue Repair. 5 Suppl
1:S292012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gedde SJ, Heuer DK and Parrish RK II: Tube
Versus Trabeculectomy Study Group: Review of results from the tube
versus trabeculectomy study. Curr Opin Ophthalmol. 21:123–128.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Seet LF, Su R, Barathi VA, Lee WS, Poh R,
Heng YM, Manser E, Vithana EN, Aung T, Weaver M, et al: SPARC
deficiency results in improved surgical survival in a novel mouse
model of glaucoma filtration surgery. PLoS One. 5:e94152010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lama PJ and Fechtner RD: Antifibrotics and
wound healing in glaucoma surgery. Surv Ophthalmol. 48:314–346.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moolten FL: Tumor chemosensitivity
conferred by inserted herpes thymidine kinase genes: Paradigm for a
prospective cancer control strategy. Cancer Res. 46:5276–5281.
1986.PubMed/NCBI
|
|
7
|
Lee YJ, Galoforo SS, Battle P, Lee H,
Corry PM and Jessup JM: Replicating adenoviral vector-mediated
transfer of a heat-inducible double suicide gene for gene therapy.
Cancer Gene Ther. 8:397–404. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karjoo Z, Chen X and Hatefi A: Progress
and problems with the use of suicide genes for targeted cancer
therapy. Adv Drug Deliv Rev. 99:113–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moriuchi S, Wolfe D, Tamura M, Yoshimine
T, Miura F, Cohen JB and Glorioso JC: Double suicide gene therapy
using a replication defective herpes simplex virus vector reveals
reciprocal interference in a malignant glioma model. Gene Ther.
9:584–591. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martín F, Chowdhury S, Neil S, Phillipps N
and Collins MK: Envelope-targeted retrovirus vectors transduce
melanoma xenografts but not spleen or liver. Mol Ther. 5:269–274.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vargas J Jr, Klotman ME and Cara A:
Conditionally replicating lentiviral-hybrid episomal vectors for
suicide gene therapy. Antiviral Res. 80:288–294. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eichman JD, Bielinska AU, Kukowska-Latallo
JF and Baker JR Jr: The use of PAMAM dendrimers in the efficient
transfer of genetic material into cells. Pharm Sci Technolo Today.
3:232–245. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Andonova VY: A new direction in ophthalmic
development: Nanoparticle drug delivery systems. Curr Pharm Des.
22:6313–6329. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chaszczewska-Markowska M, Stebelska K,
Sikorski A, Madej J, Opolski A and Ugorski M: Liposomal formulation
of 5-fluorocytosine in suicide gene therapy with cytosine
deaminase-for colorectal cancer. Cancer Lett. 262:164–172. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Duarte S, Carle G, Faneca H, de Lima MC
and Pierrefite-Carle V: Suicide gene therapy in cancer: Where do we
stand now? Cancer Lett. 324:160–170. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Candice LW, Django S and Margaret EB: The
role of herpes simplex virus-1 thymidine kinase alanine 168 in
substrate specificity. Open Biochem J. 2:60–66. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang JB, Ge J, Liu BQ, Huang B and Wei YT:
Anti-proliferative effect of herpes simplex virus thymidine kinase
gene system on human Tenon capsule fibroblasts in vitro. Zhonghua
Yan Ke Za Zhi. 42:212–217. 2006.PubMed/NCBI
|
|
18
|
Larocca C and Schlom J: Viral vector-based
therapeutic cancer vaccines. Cancer J. 17:359–371.. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kajiwara E, Kawano K, Hattori Y, Fukushima
M, Hayashi K and Maitani Y: Long-circulating liposome-encapsulated
ganciclovir enhances the efficacy of HSV-TK suicide gene therapy. J
Control Release. 120:104–110.. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Taghavi Pourianazar N and Gunduz U: CpG
oligodeoxynucleotide-loaded PAMAM dendrimer-coated magnetic
nanoparticles promote apoptosis in breast cancer cells. Biomed
Pharmacother. 78:81–91.. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Y, Wang G, Kong D, Zhang Z, Yang K,
Liu R, Zhao W and Xu Y: In vitro and in vivo double-enhanced
suicide gene therapy mediated by generation 5 polyamidoamine
dendrimers for PC-3 cell line. World J Surg Oncol. 10:32012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Choi JS, Nam K, Park JY, Kim JB, Lee JK
and Park JS: Enhanced transfection efficiency of PAMAM dendrimer by
surface modification with L-arginine. J Control Release.
99:445–456. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Denny WA: Prodrugs for gene-directed
enzyme-prodrug therapy (Suicide Gene Therapy). J Biomed Biotechnol.
2003:48–70. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jia W, Mei L, Wang Y, Liu L and Che G:
Double suicide genes selectively kill human umbilical vein
endothelial cells. Virol J. 8:742011. View Article : Google Scholar : PubMed/NCBI
|
